Comments

Plus Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Plus Therapeutics (PSTV) operate in?

Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PSTVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Fri May 30th, after the market close

Plus Therapeutics (PSTV) Forecast

News Earnings Plus Therapeutics (PSTV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Plus Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:PSTV | Benzinga

Explore Plus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PSTV.

Open	$0.34
Close	-
Volume / Avg.	1.66M / 19.99M
Day Range	$0.34 - $0.36
52 Wk Range	0.24 - 2.67
Market Cap	$2.14M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	60.31%
Days to Cover	1.77

Recent News

US Stocks Likely To Open Lower After A Solid May: 'TACO' Trade And 'Run It Hot' Optimism 'Are Consensus At This Point,' Says Expert

U.S. stock futures fell on Monday after a mixed close on Friday. Futures of major benchmark indices were trading lower in premarket.

Rishabh Mishra

Campbell's, SAIC And 3 Stocks To Watch Heading Into Monday

Avi Kapoor

This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.34
Close	-
Volume / Avg.	1.66M / 19.99M
Day Range	$0.34 - $0.36
52 Wk Range	0.24 - 2.67
Market Cap	$2.14M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	60.31%
Days to Cover	1.77

About Plus Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Plus Therapeutics (PSTV) stock?

You can purchase shares of Plus Therapeutics (NASDAQ:PSTV) through any online brokerage.

View our list of the best stock brokerages

Who are Plus Therapeutics (PSTV) competitors?

Other companies in Plus Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Alzamend Neuro (NASDAQ:ALZN), Bone Biologics (NASDAQ:BBLG), Entero Therapeutics (NASDAQ:ENTO) and Oragenics (AMEX:OGEN).

What is the forecast, or price target, for Plus Therapeutics (PSTV) stock?

Plus Therapeutics has a consensus price target of $10.63.

What is the current price for Plus Therapeutics (PSTV)?

The stock price for Plus Therapeutics (NASDAQ: PSTV) is $0.3629 last updated June 4, 2025 at 10:11 AM EDT.

Does Plus Therapeutics (PSTV) pay a dividend?

There are no upcoming dividends for Plus Therapeutics.

When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?

Plus Therapeutics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Plus Therapeutics (PSTV) going to split?

There is no upcoming split for Plus Therapeutics.

What sector and industry does Plus Therapeutics (PSTV) operate in?

Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.